Gilberto Domont
Overview
Explore the profile of Gilberto Domont including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pla I, Szabolcs B, Peter P, Ujfaludi Z, Kim Y, Horvatovich P, et al.
Int J Dermatol
. 2024 Dec;
PMID: 39722169
Background: The utilization of PD1 and CTLA4 inhibitors has revolutionized the treatment of malignant melanoma (MM). However, resistance to targeted and immune-checkpoint-based therapies still poses a significant problem. Objective: Here,...
2.
Szadai L, Bartha A, Pla Parada I, Lakatos A, Pal D, Lengyel A, et al.
Front Oncol
. 2024 Jul;
14:1428182.
PMID: 39015503
Introduction: While Immune checkpoint inhibition (ICI) therapy shows significant efficacy in metastatic melanoma, only about 50% respond, lacking reliable predictive methods. We introduce a panel of six proteins aimed at...
3.
Szadai L, Bartha A, Pla Parada I, Lakatos A, Pal D, Lengyel A, et al.
bioRxiv
. 2024 May;
PMID: 38746333
Abstract Figure:
4.
Pla I, Szabolcs B, Peter P, Ujfaludi Z, Kim Y, Horvatovich P, et al.
bioRxiv
. 2024 Mar;
PMID: 38545623
Highlights: (1) Proteogenomic subtype classification can define the landscape of genetic dependencies in melanoma (2) Nine proteins from molecular subtypes were identified as potential drug targets for specified MM patients...
5.
Correa Nascimento P, Rodrigues Junior L, Mediano M, Goncalves da Silva V, Tura B, Nogueira F, et al.
PLoS One
. 2024 Mar;
19(3):e0300918.
PMID: 38512827
Sarcopenia, a clinical syndrome primarily associated with reduced muscle mass in the elderly, has a negative impact on quality of life and survival. It can occur secondarily to other diseases...
6.
Vellasco L, Svensjo E, Bulant C, Blanco P, Nogueira F, Domont G, et al.
Pathogens
. 2022 Feb;
11(2).
PMID: 35215131
Microangiopathy may worsen the clinical outcome of Chagas disease. Given the obstacles to investigating the dynamics of inflammation and angiogenesis in heart tissues parasitized by , here we used intravital...
7.
Szadai L, Velasquez E, Szeitz B, de Almeida N, Domont G, Betancourt L, et al.
Cancers (Basel)
. 2021 Dec;
13(23).
PMID: 34885218
The discovery of novel protein biomarkers in melanoma is crucial. Our introduction of formalin-fixed paraffin-embedded (FFPE) tumor protocol provides new opportunities to understand the progression of melanoma and open the...
8.
Paik Y, Lane L, Kawamura T, Chen Y, Cho J, LaBaer J, et al.
J Proteome Res
. 2018 Oct;
17(12):4042-4050.
PMID: 30269496
An important goal of the Human Proteome Organization (HUPO) Chromosome-centric Human Proteome Project (C-HPP) is to correctly define the number of canonical proteins encoded by their cognate open reading frames...
9.
Monnerat G, Seara F, Evaristo J, Carneiro G, Evaristo G, Domont G, et al.
J Steroid Biochem Mol Biol
. 2018 Jun;
183:39-50.
PMID: 29920416
Aging is a complex process that increases the risk of chronic disease development. Hormonal and metabolic alterations occur with aging, such as androgen activity decrease. Studies aim to understand the...
10.
Fernandes L, Bassi Stern A, Cavaglieri R, Nogueira F, Domont G, Palmisano G, et al.
J Proteomics
. 2016 Jun;
151:12-23.
PMID: 27343758
Significance: CML patients treated with tyrosine kinase inhibitors (TKIs) have showed a 5-year estimated overall survival of 89%, with cumulative complete cytogenetic response of 87%. However, development of drug resistance...